Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation.
暂无分享,去创建一个
O. Viklicky | V. Švachová | I. Stříž | M. Novotný | K. Mezerová | E. Cecrdlova | L. Čurnova | M. Fialova | E. Čečrdlová | L. Čurnová | Martina Fialová
[1] Dave Singh,et al. Effects of Corticosteroids on COPD Lung Macrophage Phenotype and Function. , 2020, Clinical science.
[2] O. Viklicky,et al. Molecular Assessment of Kidney Allografts: Are We Closer to a Daily Routine? , 2020, Physiological research.
[3] M. Naesens,et al. The Causes of Kidney Allograft Failure: More Than Alloimmunity. A Viewpoint Article. , 2020 .
[4] M. Naesens,et al. The causes of kidney allograft failure: more than allo-immunity. A viewpoint paper. , 2020, Transplantation.
[5] I. Stříž,et al. Adaptive innate immunity or innate adaptive immunity? , 2019, Clinical science.
[6] T. Yeo,et al. A Novel, Five-Marker Alternative to CD16–CD14 Gating to Identify the Three Human Monocyte Subsets , 2019, Front. Immunol..
[7] J. T. Afshari,et al. Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.
[8] Yanfang Jiang,et al. Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy , 2018, Mediators of inflammation.
[9] Y. Oda,et al. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma. , 2018, Cancer research.
[10] K. Huh,et al. Clinical Significance of Macrophage Polarization in Antibody-Mediated Rejection of Renal Allograft. , 2018, Transplantation proceedings.
[11] S. Sarin,et al. Donor CD163 and nestin‐positive cells predict graft function in living donor liver transplant , 2018, Clinical transplantation.
[12] M. Stegall,et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] E. Latulippe,et al. IL‐6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T‐cell‐mediated rejection: a pilot study , 2018, Transplant international : official journal of the European Society for Organ Transplantation.
[14] Andreas Radbruch,et al. Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint , 2017, Annals of the rheumatic diseases.
[15] D. Nieboer,et al. Pretransplant Numbers of CD16+ Monocytes as a Novel Biomarker to Predict Acute Rejection After Kidney Transplantation: A Pilot Study , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] K. Caliskan,et al. CD16+ Monocytes and Skewed Macrophage Polarization Towards M2 Type Hallmark Heart Transplant Acute Cellular Rejection , 2017 .
[17] J. Kautzner,et al. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension. , 2017, Physiological research.
[18] M. Haluzík,et al. An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery. , 2017, Physiological research.
[19] Z. Al-Aly,et al. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[20] K. Caliskan,et al. CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection , 2017, Front. Immunol..
[21] Xiao-bin Cui,et al. CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma , 2017, Oncotarget.
[22] M. Netea,et al. Predominant Tubular Interleukin-18 Expression in Polyomavirus-Associated Nephropathy , 2016, Transplantation.
[23] A. Finn,et al. CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury , 2015, Nature Communications.
[24] H. Okamoto,et al. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients. , 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[25] Seungbong Han,et al. Interpreting CD56+ and CD163+ Infiltrates in Early versus Late Renal Transplant Biopsies , 2015, American Journal of Nephrology.
[26] Toshiaki Suzuki,et al. Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury , 2015, Pediatric Nephrology.
[27] D. Ingram,et al. Clinical significance of monocyte heterogeneity , 2015, Clinical and Translational Medicine.
[28] H. Møller,et al. Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti‐TNF‐α Antibody Treatment in Active Inflammatory Bowel Disease , 2014, Scandinavian journal of immunology.
[29] R. Xavier,et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.
[30] V. Lánská,et al. CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation , 2014, BMC Immunology.
[31] E. Ars,et al. Monocyte implication in renal allograft dysfunction , 2014, Clinical and experimental immunology.
[32] S. Moestrup,et al. Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages* , 2013, The Journal of Biological Chemistry.
[33] Wing-Cheong Wong,et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. , 2011, Blood.
[34] S. Moestrup,et al. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. , 2011, Immunobiology.
[35] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[36] N. Van Rooijen,et al. An Innate Response to Allogeneic Nonself Mediated by Monocytes1 , 2009, The Journal of Immunology.
[37] J. Egido,et al. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. , 2009, Atherosclerosis.
[38] T. K. van den Berg,et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. , 2009, Blood.
[39] A. Kirk,et al. Monocyte Infiltration and Kidney Allograft Dysfunction During Acute Rejection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] S. Moestrup,et al. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. , 2006, Immunobiology.
[41] T. K. van den Berg,et al. The macrophage scavenger receptor CD163. , 2005, Immunobiology.
[42] T. Langmann,et al. The Scavenger Receptor CD163: Regulation, Promoter Structure and Genomic Organization , 2000, Pathobiology.
[43] I. Stříž,et al. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. , 1993, The European respiratory journal.
[44] A. Lendlein,et al. CD14+ CD163+ IL-10+ monocytes/macrophages: Pro-angiogenic and non pro-inflammatory isolation, enrichment and long-term secretion profile. , 2010, Clinical hemorheology and microcirculation.